Related Experiment Videos
Interspecies scaling of a thienodiazepine platelet-activating factor receptor antagonist
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The pharmacokinetics of bumetanide in the newborn infant.
Biology of the neonate·1997
Efficacy and pharmacokinetics of two formulations of cyclosporine A in patients with psoriasis.
Journal of clinical pharmacology·1995
Narrow temporal therapeutic window for NMDA antagonist protection against focal cerebral ischaemia.
Neurobiology of disease·1995
High clearance of (S)-warfarin in a warfarin-resistant subject.
British journal of clinical pharmacology·1993
Cell line-dependent metabolic fate of curcumin analogs assessed by liquid chromatography with quadrupole time-of-flight mass spectrometry and subcellular microscopy.
Drug metabolism and disposition: the biological fate of chemicals·2026
Pharmacokinetics of repeated, high-dose fentanyl administration in rats.
Drug metabolism and disposition: the biological fate of chemicals·2026
Cortisol drives pregnancy-associated induction of hepatic organic anion transporter 2, sodium/taurocholate cotransporting polypeptide, and organic cation transporter 1 in HepaRG cells through glucocorticoid receptor-, hepatocyte nuclear factor 1 alpha-, and hepatocyte nuclear factor 4 alpha-dependent signaling.
Drug metabolism and disposition: the biological fate of chemicals·2026
Chromobox 4 interacts with pregnane X receptor to repress CYP3A4 expression through polycomb repressive complex 1/2-mediated epigenetic regulation.
Drug metabolism and disposition: the biological fate of chemicals·2026
Effects of simulated exogenous and endogenous lipid microenvironments on cannabidiol disposition and cytochrome P450 2C19-mediated drug interactions: New mechanistic insights.
Drug metabolism and disposition: the biological fate of chemicals·2026
Cyclosporine A, a macrocyclic peptide, is transported by organic anion transporting polypeptide 1B1/1B3 at clinically relevant doses.
Drug metabolism and disposition: the biological fate of chemicals·2026
Development of Covalent Inhibitors of Chikungunya Virus nsP2 Cysteine Protease Enabled by Direct-to-Biology Synthesis and Screening.
Journal of medicinal chemistry·2026
Discovery and Crystallographic Study of Water-Soluble Quaternary Ammonium-Based PD-1/PD-L1 Inhibitors with Anti-Angiogenic Activity.
Journal of medicinal chemistry·2026
Optimization of a Series of Novel 1H-Pyrrolo[3,2-c]pyridine-Based USP1 Inhibitors with Potent In Vivo Antitumor Activity.
Journal of medicinal chemistry·2026
Structure-Based Design and Optimization of Onradivir-Derived PB2 Inhibitors for the Treatment of Influenza A.
Journal of medicinal chemistry·2026
Ion-Channel Activity of Characteristic Alkaloids From Uncaria rhynchophylla.
Chemistry & biodiversity·2026